A national coverage determination (NCD) related to implanted cardioverter defibrillators (ICD) is causing some confusion. The NCD was issued on February 15, and the changes, while billed as “relatively minimal,” may actually require significant process alterations.
Q: We are having trouble determining what qualifies a patient as having an acute myocardial infarction (MI) and what documentation would support the diagnosis. Can you help our coding team clarify?
Q. I’ve been taught to tell our patients, “We look forward to seeing you on x day at x time with x doctor.” This has always been left on cell phone voice mails or home phones. Is this a HIPAA-compliant practice?
This week's note from the instructor highlights billing and coding regulations for specimen validity tests billed in combination with urine drug tests in the wake of an OIG audit which found a 99% error rate for these claims.
This week’s Medicare updates include a final rule on various policies throughout the Medicare program involving drug pricing, the final 2019 Medicare Advantage rate announcement and call letter, a list of newly added waived test codes, and more!
